Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 101 - 125 of 1,882
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 25, 2023

Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +29 more
Apr 4, 2023

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Optical Genome Mapping in Characterization of Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Bone Marrow samples collection
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Sickle Cell Disease, Multiple Myeloma Trial in Washington

Enrolling by invitation
  • Sickle Cell Disease
  • Multiple Myeloma
    • Washington, District of Columbia
      ASH Research Collaborative
    Mar 7, 2023

    Multiple Myeloma, Osteoporosis Trial in United States (Romosozumab)

    Recruiting
    • Multiple Myeloma
    • Osteoporosis
    • Basking Ridge, New Jersey
    • +6 more
    Mar 7, 2023

    Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2023

    Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

    Not yet recruiting
    • Multiple Myeloma
    • Smoldering Multiple Myeloma
    • Ciltacabtagene Autoleucel
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 2, 2023

    Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

    Recruiting
    • Solid Tumor
    • +11 more
    • Belfast, United Kingdom
    • +16 more
    Mar 2, 2023

    Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • Auricular Acupuncture
    • (no location specified)
    Mar 7, 2023

    Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

    Recruiting
    • Multiple Myeloma
    • BCMA CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 13, 2023

    Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

    Recruiting
    • Multiple Myeloma
    • Circadian Effective Lighting
    • Circadian Ineffective Lightning (CIL)
    • New York, New York
    • +1 more
    Feb 10, 2023

    Based on PRO Data Reported ThroughMHealth App Solution in

    Completed
    • Multiple Myeloma
    • mHealth app
    • Odense, Denmark
      Odense University Hospital
    Feb 10, 2023

    Multiple Myeloma Trial in Hangzhou (Ixazomib plus low-dose lenalidomide, Ixazomib)

    Recruiting
    • Multiple Myeloma
    • Ixazomib plus low-dose lenalidomide
    • Ixazomib
    • Hangzhou, Zhejiang, China
      Yang Xu
    Feb 9, 2023

    Multiple Myeloma Myocardial Amyloidosis Were Evaluated by NMR

    Enrolling by invitation
    • Multiple Myeloma
    • Amyloidosis Cardiac
    • NMR
    • Xi'an, Shanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Feb 6, 2023

    Multiple Myeloma Trial (Bela, Belamaf, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jan 27, 2023

    Host Microbiota and Il-17 in Favoring Multiple Myeloma

    Recruiting
    • Multiple Myeloma
      • Milan, Milano, Italy
        IRCCS Ospedale San Raffaele
      Jan 26, 2023

      Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

      Recruiting
      • Multiple Myeloma
      • New Diagnosis Tumor
      • BCMA CAR-T cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Jan 31, 2023

      Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

      Completed
      • Multiple Myeloma
      • Blood and bone marrow sampling
      • Rennes, France
        CHU Rennes
      Feb 2, 2023

      HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

      Recruiting
      • HIV
      • +5 more
      • Pfizer Bivalent COVID-19 Vaccine
      • Moderna Bivalent mRNA vaccine
      • Melbourne, Victoria, Australia
        Alfred Health
      Jan 31, 2023

      Multiple Myeloma, MDS, Diffuse Large B Cell Lymphoma Trial in Denmark (Advance consultation concerning your life and treatment

      Recruiting
      • Multiple Myeloma
      • +3 more
      • Advance consultation concerning your life and treatment (ACT )
      • Aalborg, Denmark
      • +6 more
      Jan 31, 2023

      Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Detroit, Michigan
      • +1 more
      Jan 27, 2023

      Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

      Not yet recruiting
      • Multiple Myeloma
      • Stem Cell Transplant Complications
      • PARE
      • Waitlist Control Group
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 30, 2023